Corrigendum: Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing

Scientific Reports 6: Article number: 22555; published online: 04 March 2016; updated: 07 July 2016 The Competing financial interests statement in this Article should read: “KK, WH, RK, and YZ are named inventors on patents that cover the viral gene editing technology that is the subject of this published journal article.

• Publication year

  2016

• Venue

  Scientific Reports

• Publication date

  2016-07-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/srep28213PMID 27389633PMCID 4936507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized controlled trial

  2016cited by this paper
• Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.

  2015cited by this paper
• Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease.

  2015cited by this paper
• Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells

  2015cited by this paper
• Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing

  2015cited by this paper
• Towards an HIV-1 cure: measuring the latent reservoir.

  2015cited by this paper
• Genome editing strategies: potential tools for eradicating HIV-1/AIDS

  2015cited by this paper
• CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.

  2015cited by this paper
• Negative Elongation Factor Is Required for the Maintenance of Proviral Latency but Does Not Induce Promoter-Proximal Pausing of RNA Polymerase II on the HIV Long Terminal Repeat

  2014cited by this paper
• Novel ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo

  2014cited by this paper
• The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

  2014cited by this paper
• RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection

  2014cited by this paper
• RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection

  2014cited by this paper
• Development and applications of CRISPR-Cas9 for genome engineering.

  2014cited by this paper
• Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells

  2014cited by this paper
• DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.

  2014cited by this paper
• Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease

  2013cited by this paper
• Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems

  2013cited by this paper
• Genetic Screens in Human Cells Using the CRISPR-Cas9 System

  2013cited by this paper
• Efficient In Vivo Genome Editing Using RNA-Guided Nucleases

  2013cited by this paper
• Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies

  2013cited by this paper
• Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

  2013cited by this paper
• Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy.

  2012cited by this paper
• Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

  2012cited by this paper
• Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

  2012cited by this paper
• Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2

  2011cited by this paper
• CREST maps somatic structural variation in cancer genomes with base-pair resolution

  2011cited by this paper
• A framework for variation discovery and genotyping using next-generation DNA sequencing data

  2011cited by this paper
• Epigenetic Silencing of Human Immunodeficiency Virus (HIV) Transcription by Formation of Restrictive Chromatin Structures at the Viral Long Terminal Repeat Drives the Progressive Entry of HIV into Latency

  2008cited by this paper
• Analysis of Human Immunodeficiency Virus Type 1 Gene Expression in Latently Infected Resting CD4+ T Lymphocytes In Vivo

  2003cited by this paper
• Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

  2003cited by this paper
• Synergistic Activation of Human Immunodeficiency Virus Type 1 Promoter Activity by NF-κB and Inhibitors of Deacetylases: Potential Perspectives for the Development of Therapeutic Strategies

  2002cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

  1997cited by this paper
• Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

  1997cited by this paper

• Dos herramientas de la biología sintética

  2025cites this paper
• Impact of chromatin on HIV-1 latency: a multi-dimensional perspective

  2025cites this paper
• Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets

  2023cites this paper
• Could gene therapy cure HIV?

  2021cites this paper
• Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy

  2021cites this paper
• Engineering CAR T Cells to Target the HIV Reservoir

  2020cites this paper
• HIV-1 cure strategies: why CRISPR?

  2020cites this paper
• Human Acute and Chronic Viruses: Host-Pathogen Interactions and Therapeutics

  2020cites this paper
• Block and Lock HIV Cure Strategies to Control the Latent Reservoir

  2020cites this paper
• Cas9 Cuts and Consequences; Detecting, Predicting, and Mitigating CRISPR/Cas9 On‐ and Off‐Target Damage

  2020cites this paper
• Genome editing based on CRISPR/CAS systems: beginning of a new era of genetic manipulation and inheritance

  2019cites this paper
• Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection

  2019cites this paper
• CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool

  2019cites this paper
• Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV

  2019cites this paper
• CRISPR/CAS: EL FUTURO DE LA EDICIÓN GENÉTICA

  2019cites this paper
• Gene editing and specific MicroRNA inhibition

  2019cites this paper
• Challenging the Therapy/Enhancement Distinction in CRISPR Gene Editing

  2018cites this paper
• CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering

  2018cites this paper
• Viral diversity is an obligate consideration in CRISPR/Cas9 designs for HIV cure

  2018cites this paper
• CRISPR genome editing and its medical applications

  2018cites this paper
• Rapid CRISPR/Cas9-Mediated Cloning of Full-Length Epstein-Barr Virus Genomes from Latently Infected Cells

  2018cites this paper
• Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies

  2018cites this paper
• Follicular Dendritic Cells of Lymph Nodes as Human Immunodeficiency Virus/Simian Immunodeficiency Virus Reservoirs and Insights on Cervical Lymph Node

  2018cites this paper
• The Production and Use of Transgenic Mouse Models to Study the Role of Complement Pathway Activation in Progressive Kidney Disease

  2017cites this paper
• Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants

  2017cites this paper
• CRISPR-Cas9 Gene Editing Permanently Eliminates HIV-1 DNA

  2017cites this paper
• Repair of the TGFBI gene in human corneal keratocytes derived from a granular corneal dystrophy patient via CRISPR/Cas9-induced homology-directed repair

  2017cites this paper
• Advancements in Developing Strategies for Sterilizing and Functional HIV Cures

  2017cites this paper
• Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery

  2017cites this paper
• Increasing the Clinical Potential and Applications of Anti-HIV Antibodies

  2017cites this paper
• Gene Therapy Blueprints for NeuroAIDS

  2017cites this paper
• Possible treatment of hypoxic fetal brain damage without cesarean section

  2016cites this paper
• Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8–11 December 2015, Miami, Florida, USA

  2016cites this paper
• Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study

  2016cites this paper